THE FORMULARY SYSTEM: EXPERIENCE IN INTRODUCTION AND PROSPECTS


Cite item

Full Text

Abstract

It is known that there are problems in the drug provision (DP) system virtually in all countries irrespective of the level of economic development. Because of money stringency, many countries reduce expenses on DP despite more and more increasing healthcare needs. So the problems, associated with the limited access of the population to qualitative medicaments and their rational use, have not lost their urgency. In this connection, the formulary system in the health care facilities of the Republic of Kazakhstan was studied by analyzing its legislative enactments regulating DP and by interviewing the staff of these facilities (a questionnaire method). The study has demonstrated that in Kazakhstan the formulary system needs to be improved; difficulties preserve in the creation and practical use of a drug form in health care facilities.

About the authors

G. M. Pichkhadze

S. D. Asfendiyarov Kazakh National Medical University, Almaty

E. M. Satbayeva

S. D. Asfendiyarov Kazakh National Medical University, Almaty

L. V. Kisar

S. D. Asfendiyarov Kazakh National Medical University, Almaty

Email: kisser.lida@mail.ru
преподаватель каф.

References

  1. Бейсенбаева А. А., Гуляев А. Е., Ермекбаева Б. А., Нургожин Т. С. Методические рекомендации по организации внедрения Республиканской (национальной) формулярной системы Министерства здравоохранения Республики Казахстан. — Астана, 2006. — С. 5—6.
  2. Белоусов Ю. Б., Виноградов В. А. // Фарматека. — 2005. — № 6. — С. 11—15.
  3. Гуляев А. Е. // Вестн. фармации. — 2009. — № 319. — С. 3—4.
  4. Из отчета «Подведение итогов по определению победителей среди фармацевтических компаний по закупу лекарственных средств и изделий медицинского назначения на 2011 год единым дистрибьютором ТОО "СК-Фармация"». — 2010. — С. 5—6.
  5. Политика в области информации о лекарственных средствах в странах Центральной и Восточной Европы и в Новых Независимых Государствах. Отчет о рабочем совещании ВОЗ. — Хилле-ред; Дания, 1996. — С. 1—12.
  6. WHO medicines strategy 2004—2007. Countries at the core — WH0/EDM/2004.2. C. 1—10.

Copyright (c) 2012 Eco-Vector


 


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies